<DOC>
	<DOCNO>NCT02697162</DOCNO>
	<brief_summary>Study design prospective , randomised , double-blind , interventional . Primary aim study investigate efficacy antiseptic-coated intermittent hydrophilic urinary catheter prevention reduction catheter-associated urinary tract infection child neurogenic bladder . Secondary aim assess feasibility antiseptic-coated intermittent hydrophilic urinary catheter neurogenic bladder management . Octenidine chloride use antiseptic .</brief_summary>
	<brief_title>Antiseptic-coated Intermittent Urinary Catheter</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Urinary Bladder , Neurogenic</mesh_term>
	<mesh_term>Catheter-Related Infections</mesh_term>
	<mesh_term>Anti-Infective Agents , Local</mesh_term>
	<mesh_term>Octenidine</mesh_term>
	<criteria>neurogenic bladder use intermittent catheterisation neurogenic bladder management informed oral write consent child parents/legal guardian Congenital anomaly urinary tract genitals Immunodeficiency Urinary tract fistula</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Intermittent catheterisation</keyword>
	<keyword>Antiseptic</keyword>
	<keyword>Octenidine chloride</keyword>
	<keyword>Children</keyword>
</DOC>